Fingerprint
Dive into the research topics of 'A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Alissa Visram, Suzanne R. Hayman, Angela Dispenzieri, Prashant Kapoor, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, David Dingli, Rahma Warsame, Taxiarchis Kourelis, Joselle Cook, Moritz Binder, Wilson Gonsalves, Eli Muchtar, Nelson Leung, Vivek Roy, S. Vincent Rajkumar, Shaji Kumar
Research output: Contribution to journal › Article › peer-review